Authors:
Mollgard, L
Hellberg, E
Smolowicz, A
Paul, C
Tidefelt, U
Citation: L. Mollgard et al., Interactions between P-glycoprotein and drugs used in the supportive care of acute myeloid leukemia patients, LEUK LYMPH, 42(1-2), 2001, pp. 177-185
Citation: M. Astrom et al., Adjustment of incidence rates after an estimate of completeness and accuracy in registration of acute leukemias in a Swedish population, LEUK LYMPH, 41(5-6), 2001, pp. 559-570
Authors:
Uggla, B
Mollgard, L
Stahl, E
Mossberg, LL
Karlsson, MG
Paul, C
Tidefelt, U
Citation: B. Uggla et al., Expression of topoisomerase II alpha in the G0/G1 cell cycle phase of fresh leukemic cells, LEUK RES, 25(11), 2001, pp. 961-966
Authors:
Tidefelt, U
Liliemark, J
Gruber, A
Liliemark, E
Sundman-Engberg, B
Juliusson, G
Stenke, L
Elmhorn-Rosenborg, A
Mollgard, L
Lehman, S
Xu, D
Covelli, A
Gustavsson, B
Paul, C
Citation: U. Tidefelt et al., P-glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with p-glycoprotein-positive acute myeloid leukemia, J CL ONCOL, 18(9), 2000, pp. 1837-1844
Authors:
Mollgard, L
Tidefelt, U
Sundman-Engberg, B
Lofgren, C
Paul, C
Citation: L. Mollgard et al., In vitro chemosensitivity testing in acute non lymphocytic leukemia using the bioluminescence ATP assay, LEUK RES, 24(5), 2000, pp. 445-452
Authors:
Persson, L
Vikerfors, T
Sjoberg, L
Engervall, P
Tidefelt, U
Citation: L. Persson et al., Increased incidence of bacteraemia due to viridans streptococci in an unselected population of patients with acute myeloid leukaemia, SC J IN DIS, 32(6), 2000, pp. 615-621
Authors:
Astrom, M
Bodin, L
Nilsson, I
Tidefelt, U
Citation: M. Astrom et al., Treatment, long-term outcome and prognostic variables in 214 unselected AML patients in Sweden, BR J CANC, 82(8), 2000, pp. 1387-1392